Archive ready

2025年3月期 第1四半期決算短信〔日本基準〕(連結)

https://www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20240726.pdf
May 13, 2026 at 12:45 AM JSTThe archive page, viewer, and downloads use this saved version.
May 13, 2026 at 12:45 AM JST·www.cawachi.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2025年3月期 第1四半期決算短信〔日本基準〕(連結)

StartedMay 13, 2026 at 12:45 AM JST
File size0.22 MB
SHA-256f620cbe8f0dca001661c86428f28f024bce6d62792dc87cea4f0b01b8a2c460f
About this pageAI generated

This document presents the first quarter financial results for the fiscal year ending March 2025 of Kawachi Pharmaceutical Co., Ltd. Released on July 26, 2024, it covers the consolidated performance from March 16, 2024, to June 15, 2024. The report indicates that sales reached 71.336 billion yen, a 1.1% increase compared to the same period last year. However, operating profit decreased by 8.5% to 1.605 billion yen. While there are signs of economic recovery, challenges such as rising prices and intensified competition are noted. The document also highlights ongoing efforts to strengthen the business through new store openings and the establishment of pharmacies within stores.